Brief: Gland Pharma Says USFDA Conducted Unannounced Inspection At Co’S Formulation Facility At Dundigal
Today 11:53
Oct 23 (Reuters) - Gland Pharma LtdGLAD.NS : * GLAND PHARMA- USFDA CONDUCTED UNANNOUNCED INSPECTION CGMP AT CO’S FORMULATION FACILITY AT DUNDIGAL BETWEEN OCTOBER 12 AND OCTOBER 23 * GLAND PHARMA- INSPECTION WAS CONCLUDED WITH FOUR FORM 483 OBSERVATIONS * GLAND PHARMA- OBSERVATIONS ISSUED ARE NEITHER REPEATED OBSERVATIONS NOR RELATED TO DATA INTEGRITY Source text:ID: Further company coverage:GLAD.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsBrief: Gland Pharma Says USFDA Conducted Unannounced Inspection At Co’S Formulation Facility At Dundigal
India Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln